Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-Dependent ERK activation in cerebral ischemia

Journal of Neuroscience Research

Volumn 86, Issue 12, 2008, Pages 2733-2745

  Zhao, Jie ^a   Wu, Hui Wen ^a   Chen, Yun Jiao ^a   Tian, He Ping ^a   Li, Li Xin ^a   Han, Xiao ^a   Guo, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Calcium; Ceramide; Cerebral ischemia; ERK; Neuroprotection; PP2A; Raf; Ras GRF

Indexed keywords

CALCIUM; CANTHARIDIN; CERAMIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOSPORIN A; ESTROGEN RECEPTOR ALPHA; GUANINE NUCLEOTIDE EXCHANGE FACTOR; KETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE (CALCIUM,CALMODULIN); RAF PROTEIN; SERINE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CALCIUM SIGNALING; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REGULATION; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN ISCHEMIA; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CERAMIDES; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MAP KINASE SIGNALING SYSTEM; PROTEIN PHOSPHATASE 2; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 57049099717     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21712     Document Type: Article

References (42)

1. Adams DG, Lane Coffee R. 2005. Positive regulation of Raf1- MEK1/2 -ERK1/ 2 signaling by protein serine/threonine phosphatase 2A holoenzymes. J Biol Chem 280:42644-42654.
2. Aikawa R, Komuro I.Yamazaki T, Zou Y, Kudoh S, Tanaka M. 1997. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100:1813-1821.
3. Chaudhary A, King WG, Mattaliano MD. 2000. Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr Biol 10:551-554.
4. Chen AP, Ohno M, Giese KP, Kühn R, Chen RL, Silva AJ. 2006. Forebrain-specific knockout of B-raf kinase leads to deficits in hippocampal long-term potentiation, learning, and memory. J Neurosci Res 83:28-38.
5. Choi DW, Rothman SM. 1990. The role of glutamate neurotoxicity in hypoxic- ischemic neuronal death. Annu Rev Neurosci 13:171-182.
6. Crabtree G, Olson E. 2002. NFAT signalling: choreographing the social lives of cells. Cell 109:S67-S79.
7. D'Cruz BJ, Logue ES, Falke E, DeFranco DB, Callaway CW. 2005. Hypothermia and ERK activation after cardiac arrest. Brain Res 1064:108-118.
8. Feng YZ, LeBlanc H. 2006. N-tosyl-L-phenylalanyl-chloromethyl ketone reduces ceramide during hypoxic-ischemic brain injury in newborn rat. Eur J Pharmacol 551:34-40.
9. Gao J, Duan B, Wang DG, Deng XH, Zhang G.Y, Xu L, Xu TL. 2005. Coupling between NMDA receptor and acid-sensing ion channel contributes to ischemic neuronal death. Neuron 48:635-646.
10. Glaros S, Atanaskova N, Zhao C, Skafar DF, Reddy KB. 2005. Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifen. Mol Endocrinol 20:996-1008.
11. Gu Z, Jiang Q, Zhang G, Cui Z, Zhu Z. 2000. Diphosphorylation of extracellular signal-regulated kinases and c-Jun N-terminal protein kinases in brain ischemic tolerance in rat. Brain Res 860:157-160.
12. Gu Z, Jiang Q, Zhang G. 2001. Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance. Neuroreport 12:3487-3491.
13. Guo J, Wu HW, Hu G, Han X, De W, Sun YJ. 2006. Sustained activation of Src-family tyrosine kinases by ischemia: a potential mechanism mediating extracellular signal-regulated kinase cascades in hippocampal dentate gyrus. Neuroscience 143:827-836.
14. Hetman M, Kanning K, Cavanaugh JE, Xia Z. 1999. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274:22569-22580.
15. Hu BR, Liu CL, Park DJ. 2000. Alteration of MAP kinase pathways after transient forebrain ischemia. J Cereb Blood Flow Metab 20:1089-1095.
16. Jones NM, Bergeron M. 2004. Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J Neurochem 89:157-167.
17. Kato H, Kogure K, Liu Y, Araki T, Itoyama Y. 1994. Induction of NADPH diaphorase activity in the hippocampus in a rat model of cerebral ischemia and ischemic tolerance. Brain Res 652:71-75.
18. Kitagawa K, Mabuchi T, Sugiura S, Omura-Matsuoka E, Sasaki T, Tanaka S, Matsumoto M, Hori M. 2003. CRE-mediated gene expression in cerebral ischemia. Int Congr Ser 1252:13-19.
19. Kwon DS, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. 2006. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells. Eur J Cell Biol 85:1189-1199.
20. Lee S, Yoon S, Kim DH. 2007. A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells. Gynecol Oncol 104:338-344.
21. Leonard SS, Harris G.K, Shi XL. 2004. Metal-induced oxidative stress and signal transduction. Free Radic Biol Med 37:1921-1942.
22. Mehta SL, Manhas N, Raghubir R. 2007. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54:34-66.
23. Miglietta A, Bozzo F, Gabriel L, Bocca C, Canuto RA. 2006. Extracellular signal-regulated kinase 1/2 and protein phosphatase 2A are involved in the antiproliferative activity of conjugated linoleic acid in MCF-7 cells. Br J Nutr 96:22-27.
24. Molkentin JD. 2004. Calcineurin - NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467-475.
25. Moors M, Cline JE, Abel J, Fritsche E. 2007. ERK-dependent and -independent pathways trigger human neural progenitor cell migration. Toxicol App Pharmacol 221:57-67.
26. Morrison DK, Heidecker G., Rapp UR, Copeland TD. 1993. Identification of the major phosphorylation sites of the Raf-1 kinase. J Biol Chem 268:17309-17316.
27. Park E M, Joh T H, Volpe B T, ChuC K, Song G, Cho SA. 2004. Neuroprotective role of extracellular signal regulated kinase in N-acetyl- O-methyldopamine-treated hippocampal neurons after exposure to in vivo ischemia. Neuroscience 123:147-154.
28. Prinetti A, Bassi R, Riboni L, Tettamanti G. 1997. Involvement of a ceramide activated protein phosphatase in thedifferentiation of neuroblastoma Neuro2a cells. FEBS Lett 414:475-479.
29. Ruvolo PP. 2003. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 47:383-392.
30. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9:726-735.
31. Sridhar SS, Hedley D, Siu LL. 2005. Raf kinase as a target for anticancer therapeutics, Mol Cancer Ther 4:677-685.
32. Subramaniam S, Shahani N, Strelau J, Laliberte C, Brandt R, Kaplan D, Unsicker K. 2005. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J Neurosci 25:2838-2852.
33. Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Moriguchi T. 2000 Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J Neurosci 20:4506-4514.
34. Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ. 2004. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145:3265-3272.
35. Tian XJ, Gotoh T. 2004. Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB. EMBO J 23:1567-1575.
36. Van Kanegan MJ, Adams DG., Wadzinski BE, Strack S. 2005. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J Biol Chem 280:36029-36036.
37. Willaime-Morawek S, Arbez N. 2005. IGF-I protects cortical neurons against ceramide- induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl-2? Mol Brain Res 142:97-106.
38. Wu DC, Ye W, Che XM, Yang GY. 2000. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab 20:1320-1330.
39. Xie W, Duan R, Safe S. 2001. Activation of adenosine deaminase in MCF-7 cells through IGF-estrogen receptor alpha crosstalk. J Mol Endocrinol 26:217-228.
40. Yamagishi K, Mishima K, Ohgami Y, Iwasaki K, Jimbo M, Masuda H, Igarashi Y, Inokuchi J, Fujiwara M. 2003. A synthetic ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia. Eur J Pharmacol 462:53-60.
41. Zhao X, Lorenc H, Stephenson H, Wang YJ, Witherspoon D, Katzenellenbogen B, Pfaff D, Vasudevan N. 2005. Thyroid hormone can increase estrogen-mediated transcription from a consensus estrogen response element in neuroblastoma cells. Proc Natl Acad Sci U S A 102:4890-4895.
42. Zhuravliova E, Barbakadze T, Natsvlishvili N, Mikeladze DG. 2007. Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity. Neurochem Int 50:976-982.